Jan 13, 2014
1:20
For every 20 shares held, investors received 1.
The split itself did not change the total investment value.
Heron Therapeutics, Inc. (GETTEX:AXD2) operates in the Biotechnology industry.
Heron Therapeutics, Inc. company overviewHeron Therapeutics, Inc.'s most recent stock split was on January 13, 2014. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
Heron Therapeutics, Inc. (GETTEX:AXD2) has split its stock 2 times: a 1-for-4 reverse split on May 25, 2007 and a 1-for-20 reverse split on January 13, 2014.
Heron Therapeutics, Inc. has split its stock 2 times. This history records 2 reverse splits between May 25, 2007 and January 13, 2014.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Heron Therapeutics, Inc.'s 1-for-20 reverse split on January 13, 2014, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Heron Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on January 13, 2014, 12 years ago. Companies announce splits in advance, and any new GETTEX:AXD2 split will appear on this page.